These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34135199)

  • 1. Infective Endocarditis Following Chicken Pox: A Rare Association.
    Bhatt M; Gupta N; Soneja M; DAS US; Thirumurthy V; Biswas A
    Kurume Med J; 2021 Jul; 66(2):127-133. PubMed ID: 34135199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin-resistant Staphylococcus aureus USA400 in Rio de Janeiro, Brazil.
    Damasco PV; Cavalcante FS; Chamon RC; Ferreira DC; Rioja SS; Potsch MV; Pastura MP; Marques VD; Castier MB; Marques EA; Santos KR
    Infection; 2013 Aug; 41(4):851-4. PubMed ID: 23456477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community associated methicillin resistant staphylococcus aureus (CA-MRSA) infective endocarditis in Italy.
    Bassetti M; Nicco E; Malgorzata M; Viscoli C; Valbusa A; Bongiorno D; Campanile F; Stefani S
    J Infect; 2010 Oct; 61(4):353-5. PubMed ID: 20674600
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
    Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.
    Casapao AM; Davis SL; McRoberts JP; Lagnf AM; Patel S; Kullar R; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4636-41. PubMed ID: 24890596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A successful salvage therapy with daptomycin and linezolid for right-sided infective endocarditis and septic pulmonary embolism caused by methicillin-resistant Staphylococcus aureus.
    Yazaki M; Oami T; Nakanishi K; Hase R; Watanabe H
    J Infect Chemother; 2018 Oct; 24(10):845-848. PubMed ID: 29534850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of Guillain-Barrè syndrome following Staphylococcus aureus endocarditis.
    Baravelli M; Rossi A; Picozzi A; Gavazzi A; Imperiale D; Dario P; Fantoni C; Borghi S; Anza' C
    Int J Cardiol; 2007 Jan; 114(2):E53-5. PubMed ID: 17070944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community Acquired
    Surve RM; Das BP; Venkateswaran P; Kulanthaivelu K
    Neurol India; 2022; 70(3):1200-1202. PubMed ID: 35864665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Guillain-Barré syndrome following prosthetic valve endocarditis.
    Celik T; Iyisoy A; Celik M; Baysan O; Bek S; Dogru MT
    Int J Cardiol; 2009 Mar; 133(1):102-4; author reply 104-5. PubMed ID: 17942174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA.
    To K; Miyake N; Nagasaki Y; Shimono N
    Jpn J Antibiot; 2011 Dec; 64(6):389-94. PubMed ID: 22686009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
    Rehm SJ; Boucher H; Levine D; Campion M; Eisenstein BI; Vigliani GA; Corey GR; Abrutyn E
    J Antimicrob Chemother; 2008 Dec; 62(6):1413-21. PubMed ID: 18782781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete atrioventricular block: a rare presentation of mitral valve endocarditis.
    Kitkungvan D; Suri J; Spodick D
    J Invasive Cardiol; 2010 Jan; 22(1):E1-2. PubMed ID: 20048401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina.
    Sola C; Lamberghini RO; Ciarlantini M; Egea AL; Gonzalez P; Diaz EG; Huerta V; Gonzalez J; Corso A; Vilaro M; Petiti JP; Torres A; Vindel A; Bocco JL
    Ann Clin Microbiol Antimicrob; 2011 Apr; 10():15. PubMed ID: 21527033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tricuspid valve endocarditis with daptomycin and linezolid therapy.
    Galanter KM; Ho J
    Am J Health Syst Pharm; 2019 Jul; 76(14):1033-1036. PubMed ID: 31201773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).
    Cunha BA; Pherez FM
    Eur J Clin Microbiol Infect Dis; 2009 Jul; 28(7):831-3. PubMed ID: 19184141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.
    San-Juan R; Fernández-Ruiz M; Gasch O; Camoez M; López-Medrano F; Domínguez MÁ; Almirante B; Padilla B; Pujol M; Aguado JM;
    J Antimicrob Chemother; 2017 Jul; 72(7):2102-2109. PubMed ID: 28379553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
    Duss FR; Garcia de la Mària C; Croxatto A; Giulieri S; Lamoth F; Manuel O; Miró JM
    J Antimicrob Chemother; 2019 Sep; 74(9):2626-2630. PubMed ID: 31298264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Janeway Lesion: A Forgotten Entity.
    Dash N; Verma S
    J Pediatr; 2016 May; 172():218-218.e1. PubMed ID: 26947950
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.
    Browne C; Muszbek N; Chapman R; Marsh K; Gould IM; Seaton RA; Allen M
    Int J Antimicrob Agents; 2016 May; 47(5):357-61. PubMed ID: 27061774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.